Phase II study of oxaliplatin, fluorouracil, and folinic acid in locally advanced or metastatic gastric cancer patients

To evaluate the efficacy and safety of an oxaliplatin, fluorouracil (5-FU), and folinic acid (FA) combination in patients with metastatic or advanced gastric cancer (M/AGC). Of the 54 eligible patients with measurable or assessable M/AGC, 53 received oxaliplatin 100 mg/m(2) and FA 400 mg/m(2) (2-hou...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	Journal of clinical oncology Ročník 20; číslo 23; s. 4543
Hlavní autori:	Louvet, C, André, T, Tigaud, J M, Gamelin, E, Douillard, J Y, Brunet, R, François, E, Jacob, J H, Levoir, D, Taamma, A, Rougier, P, Cvitkovic, E, de Gramont, A
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	United States 01.12.2002
Predmet:	Adenocarcinoma - drug therapy Adenocarcinoma - secondary Adult Aged Antineoplastic Combined Chemotherapy Protocols - adverse effects Antineoplastic Combined Chemotherapy Protocols - therapeutic use Drug Administration Schedule Female Fluorouracil - administration & dosage Humans Leucovorin - administration & dosage Male Middle Aged Organoplatinum Compounds - administration & dosage Stomach Neoplasms - drug therapy Stomach Neoplasms - pathology Survival Analysis Treatment Outcome
ISSN:	0732-183X
On-line prístup:	Zistit podrobnosti o prístupe
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Buďte prvý, kto okomentuje tento záznam!